Accepted for Publication: October 19, 2021.
Published Online: December 9, 2021. doi:10.1001/jamaophthalmol.2021.5201
Corresponding Author: Avinash Ingole, MS, Department of Ophthalmology, Topiwala National Medical College, BYL Nair Charitable Hospital, Mumbai Central, OPD Building, 2nd Floor, Mumbai, Maharashtra 400 008, India (dr.avinshingole@yahoo.com).
Author Contributions: Mr Ingole had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Choksi, Agrawal, Date, Rathod, Ingole.
Acquisition, analysis, or interpretation of data: Choksi, Date, Gharat, Ingole, Chaudhari, Pawar.
Drafting of the manuscript: Choksi, Date, Ingole, Chaudhari.
Critical revision of the manuscript for important intellectual content: Choksi, Agrawal, Date, Rathod, Gharat, Ingole, Pawar.
Statistical analysis: Choksi, Date, Rathod, Ingole, Pawar.
Administrative, technical, or material support: Choksi, Date, Gharat, Chaudhari, Pawar.
Supervision: Choksi, Agrawal, Rathod, Gharat, Ingole.
Conflict of Interest Disclosures: None reported.
Additional Contributions: Dilip Asgaonkar, MD, Girish Rajadhyaksha, MD, Rosemarie DeSouza, MD, Vrinda Kulkarn, MD, Mala Kaneria, MD, and Santosh Gosavi, MD, Department of Internal Medicine, Topiwala National Medical College, BYL Nair Charitable Hospital, Mumbai Central, India, contributed clinical management of patient and systemic complications during the course of admission. Bachi Hatiram, MS, Sanjay Chhabria, MS, and Vicky Khattar, MS, Department of Otorhinolaryngology, Topiwala National Medical College, BYL Nair Charitable Hospital, managed the otorhinolaryngology aspect of patient treatment during the course of admission. Sabyasachi Sengupta, DO, DNB, Sengupta’s Research Academy, Mumbai, India, assisted with statistical analysis and manuscript writing. No compensation was received by any of these individuals except Dr Sengupta for their services.
Additional Information: We thank the wife of the deceased patient in the promotional image for consenting to publish the photograph.
1.Ahmadikia
K , Hashemi
SJ , Khodavaisy
S ,
et al. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis.
Mycoses. 2021;64(8):798-808. doi:
10.1111/myc.13256
PubMedGoogle ScholarCrossref 4.Sen
M , Honavar
SG , Bansal
R ,
et al; Members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group. Epidemiology, clinical profile, management, and outcome of COVID-19–associated rhino-orbital-cerebral mucormycosis in 2826 patients in India: Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), report 1.
Indian J Ophthalmol. 2021;69(7):1670-1692. doi:
10.4103/ijo.IJO_1565_21
PubMedGoogle ScholarCrossref 11.Avatef Fazeli
M , Rezaei
L , Javadirad
E ,
et al. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: an observational study.
Mycoses. 2021;64(11):1366-1377. doi:
10.1111/myc.13351
PubMedGoogle ScholarCrossref 13.Lanternier
F , Poiree
S , Elie
C ,
et al; French Mycosis Study Group. Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
J Antimicrob Chemother. 2015;70(11):3116-3123. doi:
10.1093/jac/dkv236
PubMedGoogle ScholarCrossref